CLINICAL_TRIALS
trial_result
· 2019-11-22
Clinical Trial Update: Erlotinib in Women With Previously Untreated Adenocarcinoma of the Lung [Phase 2]
Summary
Phase 2 trial update evaluating erlotinib in women with previously untreated adenocarcinoma of the lung.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pasi A. Janne, MD, PhD | Conditions: Adenocarcinoma, Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-11-22